This Biotech Stock Flies High After CBD Oil Gains Approval In EuropeInvestors Business Daily • 09/23/19
GW Pharma gets EU approval for cannabis-based drug as treatment for severe childhood epilepsyMarket Watch • 09/23/19
GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsyGlobeNewsWire • 09/23/19
Is GW Pharmaceuticals (GWPH) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 09/20/19
GW Pharmaceuticals Isn't a Cannabis Stock -- and 4 Other Things Its CEO Wants You to KnowThe Motley Fool • 09/12/19
Has GW Pharmaceuticals (GWPH) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 09/04/19
GW Pharmaceuticals to Present at the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, September 11th, 2019GlobeNewsWire • 09/04/19
Kalytera Is Set To Become The Next GW Pharma After Groundbreaking Phase 2 Trial ResultsSeeking Alpha • 08/26/19
These 10 Pot Stocks Have Lost Nearly $21 Billion in Aggregate Value in 4 MonthsThe Motley Fool • 08/26/19